Precigen, Inc. (PGEN)
8.54
+0.33
(+4.02%)
USD |
NASDAQ |
Oct 02, 16:00
8.52
-0.02
(-0.23%)
After-Hours: 20:00
Precigen EPS Diluted (Quarterly) : 0.0485 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0485 |
| March 31, 2026 | -0.0224 |
| December 31, 2025 | -0.0664 |
| September 30, 2025 | -1.059 |
| June 30, 2025 | -0.0899 |
| March 31, 2025 | -0.1843 |
| December 31, 2024 | -0.0674 |
| September 30, 2024 | -0.0869 |
| June 30, 2024 | -0.233 |
| March 31, 2024 | -0.0952 |
| December 31, 2023 | -0.1328 |
| September 30, 2023 | -0.0796 |
| June 30, 2023 | -0.0819 |
| March 31, 2023 | -0.0989 |
| December 31, 2022 | -0.1065 |
| September 30, 2022 | -0.0365 |
| June 30, 2022 | -0.088 |
| March 31, 2022 | -0.0964 |
| December 31, 2021 | -0.1211 |
| September 30, 2021 | -0.1494 |
| June 30, 2021 | -0.1007 |
| March 31, 2021 | -0.0895 |
| December 31, 2020 | -0.2338 |
| September 30, 2020 | -0.1783 |
| June 30, 2020 | -0.2642 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3534 |
| December 31, 2019 | -1.090 |
| September 30, 2019 | -0.3469 |
| June 30, 2019 | -0.2521 |
| March 31, 2019 | -0.3969 |
| December 31, 2018 | -2.588 |
| September 30, 2018 | -0.4426 |
| June 30, 2018 | -0.51 |
| March 31, 2018 | -0.33 |
| December 31, 2017 | -0.23 |
| September 30, 2017 | -0.33 |
| June 30, 2017 | -0.16 |
| March 31, 2017 | -0.26 |
| December 31, 2016 | -0.37 |
| September 30, 2016 | -0.24 |
| June 30, 2016 | -0.42 |
| March 31, 2016 | -0.55 |
| December 31, 2015 | -0.28 |
| September 30, 2015 | -0.34 |
| June 30, 2015 | -0.37 |
| March 31, 2015 | 0.25 |
| December 31, 2014 | 0.18 |
| September 30, 2014 | -0.53 |
| June 30, 2014 | -0.53 |
| March 31, 2014 | 0.04 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.0884 |
| AC Immune SA | 0.026 |
| Amgen, Inc. | 4.366 |
| Geron Corp. | -0.0249 |
| Neurocrine Biosciences, Inc. | 1.386 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 20.07M |
| Revenue (Quarterly) | 54.98M |
| Total Expenses (Quarterly) | 34.91M |
| Enterprise Value | 3.118B |
| Gross Profit Margin (Quarterly) | 94.32% |
| Profit Margin (Quarterly) | 36.51% |
| Earnings Yield | -12.87% |
| Normalized Earnings Yield | -9.898 |